These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11711531)

  • 1. A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-beta signaling.
    Bai S; Cao X
    J Biol Chem; 2002 Feb; 277(6):4176-82. PubMed ID: 11711531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
    Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
    J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles for the MH2 domain of Smad7 in the specific inhibition of transforming growth factor-beta superfamily signaling.
    Mochizuki T; Miyazaki H; Hara T; Furuya T; Imamura T; Watabe T; Miyazono K
    J Biol Chem; 2004 Jul; 279(30):31568-74. PubMed ID: 15148321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription.
    Lin X; Liang YY; Sun B; Liang M; Shi Y; Brunicardi FC; Shi Y; Feng XH
    Mol Cell Biol; 2003 Dec; 23(24):9081-93. PubMed ID: 14645520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of transforming growth factor-beta signaling by protein inhibitor of activated STAT, PIASy through Smad3.
    Imoto S; Sugiyama K; Muromoto R; Sato N; Yamamoto T; Matsuda T
    J Biol Chem; 2003 Sep; 278(36):34253-8. PubMed ID: 12815042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad6 as a transcriptional corepressor.
    Bai S; Shi X; Yang X; Cao X
    J Biol Chem; 2000 Mar; 275(12):8267-70. PubMed ID: 10722652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function relationship of inhibitory Smads: Structural flexibility contributes to functional divergence.
    Hariharan R; Pillai MR
    Proteins; 2008 Jun; 71(4):1853-62. PubMed ID: 18175316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory smads and tgf-Beta signaling in glomerular cells.
    Schiffer M; Schiffer LE; Gupta A; Shaw AS; Roberts IS; Mundel P; Böttinger EP
    J Am Soc Nephrol; 2002 Nov; 13(11):2657-66. PubMed ID: 12397035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissection of inhibitory Smad proteins: both N- and C-terminal domains are necessary for full activities of Xenopus Smad6 and Smad7.
    Nakayama T; Berg LK; Christian JL
    Mech Dev; 2001 Feb; 100(2):251-62. PubMed ID: 11165482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
    Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
    J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressions of inhibitory Smads, Smad6 and Smad7, are differentially regulated by TPA in human lung fibroblast cells.
    Tsunobuchi H; Ishisaki A; Imamura T
    Biochem Biophys Res Commun; 2004 Apr; 316(3):712-9. PubMed ID: 15033458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
    Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
    EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1beta.
    Kaiser M; Haag J; Söder S; Bau B; Aigner T
    Arthritis Rheum; 2004 Nov; 50(11):3535-40. PubMed ID: 15529348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7.
    Inamoto S; Iwata S; Inamoto T; Nomura S; Sasaki T; Urasaki Y; Hosono O; Kawasaki H; Tanaka H; Dang NH; Morimoto C
    Oncogene; 2007 Feb; 26(6):893-904. PubMed ID: 16909115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta1 induces nuclear export of inhibitory Smad7.
    Itóh S; Landström M; Hermansson A; Itoh F; Heldin CH; Heldin NE; ten Dijke P
    J Biol Chem; 1998 Oct; 273(44):29195-201. PubMed ID: 9786930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads.
    Akiyoshi S; Inoue H; Hanai J; Kusanagi K; Nemoto N; Miyazono K; Kawabata M
    J Biol Chem; 1999 Dec; 274(49):35269-77. PubMed ID: 10575014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new partner for inhibitory Smads.
    Miyazono K
    Cytokine Growth Factor Rev; 2002 Feb; 13(1):7-9. PubMed ID: 11750875
    [No Abstract]   [Full Text] [Related]  

  • 19. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
    Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
    Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The balance between acetylation and deacetylation controls Smad7 stability.
    Simonsson M; Heldin CH; Ericsson J; Grönroos E
    J Biol Chem; 2005 Jun; 280(23):21797-803. PubMed ID: 15831498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.